Strengths and limitations of meta-analysis: Larger studies may be more reliable

Peto, 1976, Design and analysis of randomized clinical trials requiring prolonged observation of each patient. 1. Introduction and design, Br J Cancer, 34, 585, 10.1038/bjc.1976.220

Peto, 1977, Design and analysis of randomized clinical trials requiring prolonged observation of each patient. 2. Analysis and examples, Br J Cancer, 35, l, 10.1038/bjc.1977.1

Pocock, 1983

Yusuf, 1984, Why do we need some large, simple randomized trials?, Stat Med., 3, 409, 10.1002/sim.4780030421

Peto, 1978, Clinical trial methodology, Biomedicine, 28, 24

Collins, 1987, Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews, Stat Med, 6, 245, 10.1002/sim.4780060308

Yusuf, 1987, Obtaining medically meaningful answers from an overview of randomized clinical trials, Stat Med, 6, 281, 10.1002/sim.4780060314

Peto, 1987, Why do we need systematic overviews of randomized trials, Stat Med, 6, 233, 10.1002/sim.4780060306

Yusuf, 1985, Beta blockade during and after myocardial infarction: an overview of the randomized trials, Prog Cardiovasc Dis, 27, 335, 10.1016/S0033-0620(85)80003-7

Chalmers, 1987, Meta-analysis of clinical trials as a scientific discipline I: control of bias and comparison with large co-operative trials, Stat Med, 6, 315, 10.1002/sim.4780060320

Furberg, 1987, Lessons from overviews of cardiovascular trials, Stat Med, 6, 295, 10.1002/sim.4780060316

Thompson, 1991, Can meta-analyses be trusted?, Lancet, 338, 1127, 10.1016/0140-6736(91)91975-Z

Chalmers, 1991, Problems induced by meta-analyses, Stat Med, 10, 971, 10.1002/sim.4780100618

Moher, 1995, Assessing the quality of randomized controlled rials: an annotated bibliography of scales and checklists, Controlled Clin Trials, 16, 62, 10.1016/0197-2456(94)00031-W

Greenland, 1994, Invited commentary: a critical look at some popular meta-analytic methods, Am J Epidemiol, 140, 290, 10.1093/oxfordjournals.aje.a117248

Simes, 1987, Confronting publication bias: a cohort design for meta-analysis, Stat Med, 6, 11, 10.1002/sim.4780060104

Dickersin, 1987, Publication bias and clinical trials, Controlled Clin Trials, 8, 343, 10.1016/0197-2456(87)90155-3

Easterbrook, 1991, Publication bias in clinical research, Lancet, 337, 867, 10.1016/0140-6736(91)90201-Y

Moher, 1996, Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews, Lancet, 347, 363, 10.1016/S0140-6736(96)90538-3

1994, Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients, Lancet, 343, 311, 10.1016/S0140-6736(94)91161-4

1994, Collaborative overview of randomised trials of antiplatelet therapy Part 1: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients, BMJ, 308, 81, 10.1136/bmj.308.6921.81

Yusuf, 1994, Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration, Lancet, 344, 563, 10.1016/S0140-6736(94)91963-1

1995, Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesteroltreatment regimens, Am J Cardiol, 75, 1130, 10.1016/S0002-9149(99)80744-9

Pocock, 1990, Estimation issues in clinical trials and overviews, Stat Med, 9, 657, 10.1002/sim.4780090612

Demets, 1987, Methods for combining randomized clinical trials: strengths and limitations, Stat Med, 6, 341, 10.1002/sim.4780060325

Bailey, 1987, Inter-study differences: how should they influence the interpretation and analysis of results?, Stat Med, 6, 351, 10.1002/sim.4780060327

Berlin, 1989, A comparison of statistical methods for combining event rates from clinical trials, Stat Med, 8, 141, 10.1002/sim.4780080202

Goodman, 1989, Meta-analysis and evidence, Controlled Clin Trials, 10, 188, 10.1016/0197-2456(89)90030-5

DerSimonian, 1986, Meta-analysis in clinical trials, Controlled Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2

Teo, 1991, Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials, BMJ, 303, 1499, 10.1136/bmj.303.6816.1499

Yusuf, 1985, Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials, Eur Heart J, 6, 556, 10.1093/oxfordjournals.eurheartj.a061905

Horner, 1992, Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality, Circulation, 86, 774, 10.1161/01.CIR.86.3.774

Stampfer, 1982, Effect of intravenous streptokinase on acute myocardial infarction, N Engl J Med, 307, 1180, 10.1056/NEJM198211043071904

Donner, 1984, Approaches to sample size estimation in the design of clinical trials-a review, Stat Med, 3, 199, 10.1002/sim.4780030302

Woods, 1992, Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2), Lancet, 339, 1553, 10.1016/0140-6736(92)91828-V

1995, ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction, Lancet, 345, 669, 10.1016/S0140-6736(95)90865-X

Smith, 1986, Intravenous infusion of magnesium sulphate after acute myocardial infarction: effects on arrhythmias and mortality, Int J Cardiol, 12, 175, 10.1016/0167-5273(86)90239-1

Borzak, 1995, Discordance between meta-analyses and large-scale randomized, controlled trials, Ann Int Med, 123, 873, 10.7326/0003-4819-123-11-199512010-00010

Woods, 1995, Mega-trials and management of acute myocardial infarction, Lancet, 346, 611, 10.1016/S0140-6736(95)91440-4

Antman, 1995, Magnesium in acute MI. Timing is critical, Circulation, 92, 2367, 10.1161/01.CIR.92.9.2367

Yusuf, 1995, Magnesium in acute myocardial infarction, BMJ, 310, 751, 10.1136/bmj.310.6982.751

1986, Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction, Lancet, i, 397

1988, Lancet, ii, 349

Wilcox, 1988, Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction (Anglo-Scandinavian Study of Early Thrombolysis), Lancet, ii, 525, 10.1016/S0140-6736(88)92656-6

Meinert, 1988, Toward prospective registration of clinical trials, Controlled Clin Trials, 9, 1, 10.1016/0197-2456(88)90002-5

Olkin, 1995, Meta-analysis: reconciling the results of independent studies, Stat Med, 14, 457, 10.1002/sim.4780140507